We are live on ! Find out more
CASI

CASI Pharmaceuticals

Delisted

CASI was delisted on the 25th of February, 2026.

50 hedge funds and large institutions have $37.3M invested in CASI Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 10

13% more capital invested

Capital invested by funds: $32.9M → $37.3M (+$4.35M)

0.01% more ownership

Funds ownership: 1.2%1.22% (+0.01%)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

4% less funds holding

Funds holding: 5250 (-2)

Holders
50
Holders Change
-2
Holders Change %
-3.85%
% of All Funds
1.09%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
19
Reduced
10
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
51
Renaissance Technologies
New York
-$120K -4,194 Closed
JT
52
Jump Trading
Illinois
-$47K -1,632 Closed
Marshall Wace
53
Marshall Wace
United Kingdom
-$44K -1,525 Closed
CS
54
Credit Suisse
Switzerland
-$37K -1,319 Closed
Fidelity Investments
55
Fidelity Investments
Massachusetts
+$128 +4 New